Invention Grant
- Patent Title: Substance binding human IgG Fc receptor IIb (FcγRIIb)
- Patent Title (中): 物质结合人IgG Fc受体IIb（FcγRIIb）
-
Application No.: US10580813Application Date: 2004-11-26
-
Publication No.: US08853363B2Publication Date: 2014-10-07
- Inventor: Robert Huber , Peter Sondermann , Uwe Jacob , Kerstin Wendt , Chiara Cabrele , Luis Moroder
- Applicant: Robert Huber , Peter Sondermann , Uwe Jacob , Kerstin Wendt , Chiara Cabrele , Luis Moroder
- Applicant Address: DE München
- Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee Address: DE München
- Agency: Fulbright & Jaworski LLP
- Priority: EP03027000 20031126
- International Application: PCT/EP2004/013450 WO 20041126
- International Announcement: WO2005/051999 WO 20050609
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; C07K14/735 ; C07K16/28 ; C07K1/00 ; A61K39/00
Abstract:
The invention relates to novel immunogens carrying conformationally discriminating epitopes (CDEs) and to immunization methods for producing antibodies that specifically recognize proteins with very closely related homologues. In particular, the invention relates to antibodies which are specific for either FcγRIIb or FcγRIIa.
Public/Granted literature
- US20080014141A1 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) Public/Granted day:2008-01-17
Information query
